abstract |
The invention provides compounds of Formula I:n nAzabicyclo-N(R 1 )—C(═X)—W Formula In nThese compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which α7 is known to be involved. |